Phathom Pharmaceuticals I...
6.76
-0.03 (-0.44%)
At close: Jan 15, 2025, 11:41 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -201.59M -197.72M -143.88M -129.07M -255.13M -1.29M
Depreciation & Amortization 575.00K 620.00K 521.00K 323.00K 8.00K n/a
Stock-Based Compensation 45.02M 24.13M 16.81M 5.84M 406.00K n/a
Other Working Capital -8.97M -3.24M -17.68M 27.71M -11.79M -10.00K
Other Non-Cash Items 32.06M 21.00M 5.41M 1.59M 131.46M 50.00K
Deferred Income Tax n/a n/a n/a -95.00K 96.27M n/a
Change in Working Capital -13.64M 5.44M -27.48M 51.72M -9.52M 215.00K
Operating Cash Flow -137.58M -146.53M -148.62M -69.69M -36.51M -1.02M
Capital Expenditures -1.63M -1.04M -328.00K -1.04M -25.25M n/a
Acquisitions n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -1.18M -330.00K -1.19M -25.12M n/a
Investing Cash Flow -1.63M -1.04M -328.00K -1.04M -25.25M n/a
Debt Repayment 39.32M n/a 42.76M 25.00M 24.85M 1.90M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 172.80M 95.45M 1.94M 629.00K 279.80M 2.00K
Financial Cash Flow 367.58M 120.04M 44.71M 114.46M 304.65M 1.90M
Net Cash Flow 228.37M -27.53M -104.24M 43.73M 242.89M 879.00K
Free Cash Flow -139.21M -147.57M -148.94M -70.73M -61.76M -1.02M